6

NuPathe Inc. Completes $30 Million Series B Financing (Business Wire)

http://us.rd.yahoo.com –

CONSHOHOCKEN, Pa.----NuPathe Inc., a privately held specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, announced that the company has raised $30 million in a recently completed Series B equity financing.

Read »
16 weeks 6 days ago – Made popular 16 weeks 6 days ago
Category: Venture Capital   Tags:

Similar stories

NuPathe Raises $30 Million 16 weeks 6 days ago
Alnara Pharmaceuticals, Inc. Secures $20 Million in Series A Round (Business Wire) 2 weeks 6 days ago
Alnara Pharmaceuticals, Inc. Secures $20 Million in Series A Round (Business Wire) 2 weeks 6 days ago
Link Medicine Completes $40 million Series C Financing to Accelerate Development of First Disease-Modifying Treatments for Neuro 7 weeks 1 day ago
  • Anonymous
  • american
  • anon
  • dennis
  • massquant
  • traderbyday

Navigation

User login

What we're reading:

cover of The Education of a Speculator
The Education of a Speculator

If you don't see your content here, learn more about importing to on this page.
Private Equity News and Advice